Cambridge, MA, United States of America

Jan Antionette C Romero

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ariad Pharmaceuticals, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Antionette C Romero. Retrieved from https://idiyas.com/inventor/jan-antionette-c-romero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Antionette C Romero: Innovator in Kinase Inhibitors

Introduction

Jan Antionette C Romero is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. His work is essential in advancing therapeutic options for various diseases.

Latest Patents

Jan Antionette C Romero holds a patent for "Substituted acetylenic imidazo[1,2-B]pyridazine compounds as kinase inhibitors." This invention relates to compounds of the general formula that have potential applications in treating diseases by inhibiting specific kinases. He has 1 patent to his name, showcasing his innovative approach to drug development.

Career Highlights

Romero is currently associated with Ariad Pharmaceuticals, Inc., where he continues to work on groundbreaking research in the pharmaceutical industry. His expertise in the field has positioned him as a valuable asset to his team and the company.

Collaborations

Throughout his career, Jan has collaborated with talented individuals such as Jiwei Qi and Dong Zou. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Jan Antionette C Romero is a distinguished inventor whose work in kinase inhibitors is paving the way for new therapeutic advancements. His contributions to the field are invaluable, and his ongoing research promises to impact the pharmaceutical landscape significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…